Refillable ranibizumab device shows promising phase 2 efficacy
- Posted on: Aug 19 2019
- Leave a response
Researchers assessed the safety and efficacy of the ranibizumab Port Delivery System (PDS) for neovascular AMD.
Source: AAO
Posted in: Uncategorized
